诺华同意以120亿美元收购美国创新药公司Avidity

格隆汇
Oct 27, 2025

诺华公司同意以每股72美元现金作价(约46%溢价)收购生物技术公司Avidity Biosciences,交易总值120亿美元。Avidity正在开发治疗罕见疾病的实验性药物,其中包括针对神经肌肉疾病。若今次收购成功,预料可为制药业并购潮推波助澜。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10